Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Aster Whitefield Hospital, with 506 beds, opened.

2.

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

3.

A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.

4.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

5.

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot